title: Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
abstract: Lung cancer is the most common cause of cancer deaths worldwide. The two broad histological subtypes of lung cancer are small-cell lung cancer (SCLC), which is the cause of 15% of cases, and non-small-cell lung cancer (NSCLC), which accounts for 85% of cases and includes adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma. Although NSCLC and SCLC are commonly thought to be different diseases owing to their distinct biology and genomic abnormalities, the idea that these malignant disorders might share common cells of origin has been gaining support. This idea has been supported by the unexpected findings that a subset of NSCLCs with mutated EGFR return as SCLC when resistance to EGFR tyrosine kinase inhibitors develops. Additionally, other case reports have described the coexistence of NSCLC and SCLC, further challenging the commonly accepted view of their distinct lineages. Here, we summarise the published clinical observations and biology underlying tumours with combined SCLC and NSCLC histology and cancers that transform from adenocarcinoma to SCLC. We also discuss pre-clinical studies pointing to common potential cells of origin, and speculate how the distinct paths of differentiation are determined by the genomics of each disease.
authors.affiliation: Massachusetts General Hospital Cancer Center, Department of Medicine and Harvard Medical School, Boston, MA 02114, USA.
authors.forename: Matthew G
authors.initials: MG
authors.lastname: Oser
authors.affiliation: Massachusetts General Hospital Cancer Center, Department of Medicine and Harvard Medical School, Boston, MA 02114, USA.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Niederst
authors.affiliation: Massachusetts General Hospital Cancer Center, Department of Medicine and Harvard Medical School, Boston, MA 02114, USA.
authors.forename: Lecia V
authors.initials: LV
authors.lastname: Sequist
authors.affiliation: Massachusetts General Hospital Cancer Center, Department of Medicine and Harvard Medical School, Boston, MA 02114, USA. Electronic address: jengelman@partners.org.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Engelman
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000473:pathology*; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology*; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics; D006801:Humans; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D055752:Small Cell Lung Carcinoma / Q000235:genetics / Q000473:pathology*
chemical_list: D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors
references.citation: Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4952-7
references.pmid: 24586047
references.citation: Nat Commun. 2015;6:6377
references.pmid: 25758528
references.citation: Nature. 1995 Jul 27;376(6538):337-41
references.pmid: 7630400
references.citation: Dev Biol. 1997 Jun 15;186(2):224-36
references.pmid: 9205141
references.citation: Cancer. 2005 Mar 15;103(6):1172-8
references.pmid: 15700264
references.citation: J Natl Cancer Inst. 1987 Sep;79(3):403-7
references.pmid: 3476783
references.citation: J Clin Oncol. 1989 May;7(5):607-12
references.pmid: 2540288
references.citation: Nature. 1992 Sep 24;359(6393):295-300
references.pmid: 1406933
references.citation: Cancer Cell. 2003 Sep;4(3):181-9
references.pmid: 14522252
references.citation: Development. 2004 Sep;131(17):4299-310
references.pmid: 15294860
references.citation: Chest. 1986 May;89(5):699-704
references.pmid: 3009096
references.citation: Br J Cancer. 1986 Aug;54(2):265-9
references.pmid: 3017396
references.citation: Lung Cancer. 2005 Apr;48(1):141-4
references.pmid: 15777982
references.citation: Lancet. 2005 Oct 15-21;366(9494):1385-96
references.pmid: 16226617
references.citation: Lung Cancer. 2006 Apr;52(1):93-7
references.pmid: 16488055
references.citation: Ann Oncol. 2006 Jun;17(6):1028-9
references.pmid: 16357019
references.citation: N Engl J Med. 2006 Jul 13;355(2):213-5
references.pmid: 16837691
references.citation: Science. 2007 May 18;316(5827):1039-43
references.pmid: 17463250
references.citation: Cancer Sci. 2007 Nov;98(11):1714-9
references.pmid: 17784875
references.citation: Lung Cancer. 2007 Dec;58(3):411-3
references.pmid: 17601631
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2070-5
references.pmid: 18227510
references.citation: Clin Cancer Res. 2008 May 15;14(10):2895-9
references.pmid: 18483355
references.citation: J Clin Oncol. 2008 Jul 20;26(21):3543-51
references.pmid: 18506025
references.citation: Clin Cancer Res. 2008 Oct 1;14(19):6092-6
references.pmid: 18829487
references.citation: Pathol Oncol Res. 2008 Dec;14(4):373-9
references.pmid: 18985444
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4787-92
references.pmid: 19720897
references.citation: Lancet Oncol. 2010 Feb;11(2):121-8
references.pmid: 20022809
references.citation: Cancer Sci. 2010 Jan;101(1):161-6
references.pmid: 19811498
references.citation: N Engl J Med. 2010 Jun 24;362(25):2380-8
references.pmid: 20573926
references.citation: N Engl J Med. 2010 Oct 28;363(18):1693-703
references.pmid: 20979469
references.citation: J Clin Invest. 2010 Dec;120(12):4478-92
references.pmid: 21099110
references.citation: J Thorac Oncol. 2011 Jan;6(1):195-8
references.pmid: 21178714
references.citation: Sci Transl Med. 2011 Mar 23;3(75):75ra26
references.pmid: 21430269
references.citation: Cancer Cell. 2011 Jun 14;19(6):754-64
references.pmid: 21665149
references.citation: Lancet Oncol. 2011 Aug;12(8):735-42
references.pmid: 21783417
references.citation: Cell Cycle. 2011 Aug 15;10(16):2806-15
references.pmid: 21822053
references.citation: Lancet. 2011 Nov 12;378(9804):1741-55
references.pmid: 21565397
references.citation: Lancet. 2011 Nov 12;378(9804):1727-40
references.pmid: 21565398
references.citation: Ann Oncol. 2011 Dec;22(12):2616-24
references.pmid: 22071650
references.citation: Neoplasma. 2012;59(1):100-4
references.pmid: 22103903
references.citation: Clin Lung Cancer. 2012 Jan;13(1):75-9
references.pmid: 21729654
references.citation: Lancet Oncol. 2012 Mar;13(3):239-46
references.pmid: 22285168
references.citation: Cancer Discov. 2012 Sep;2(9):798-811
references.pmid: 22961666
references.citation: Cell. 2012 Sep 14;150(6):1107-20
references.pmid: 22980975
references.citation: Nat Genet. 2012 Oct;44(10):1104-10
references.pmid: 22941188
references.citation: Nat Genet. 2012 Oct;44(10):1111-6
references.pmid: 22941189
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17531-6
references.pmid: 23047698
references.citation: Ann Oncol. 2012 Dec;23(12):3188-9
references.pmid: 23079729
references.citation: PLoS One. 2012;7(12):e53817
references.pmid: 23285300
references.citation: J Natl Compr Canc Netw. 2013 Jan 1;11(1):78-98
references.pmid: 23307984
references.citation: J Clin Oncol. 2013 Mar 10;31(8):1070-80
references.pmid: 23401451
references.citation: Lung Cancer. 2013 Apr;80(1):1-4
references.pmid: 23312887
references.citation: Sci Signal. 2013 Apr 2;6(269):pl1
references.pmid: 23550210
references.citation: Clin Cancer Res. 2013 Apr 15;19(8):2240-7
references.pmid: 23470965
references.citation: J Clin Oncol. 2013 Sep 20;31(27):3327-34
references.pmid: 23816960
references.citation: J Clin Pathol. 2013 Oct;66(10):839-46
references.pmid: 23661716
references.citation: Lung Cancer. 2013 Nov;82(2):370-2
references.pmid: 24012411
references.citation: Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):255-60
references.pmid: 24367082
references.citation: J Thorac Oncol. 2013 Oct;8(10):1265-71
references.pmid: 24457237
references.citation: Lancet Oncol. 2014 Feb;15(2):213-22
references.pmid: 24439929
references.citation: Clin Cancer Res. 2014 Feb 15;20(4):890-903
references.pmid: 24323898
references.citation: Nature. 2014 Mar 13;507(7491):190-4
references.pmid: 24499815
references.citation: N Engl J Med. 2014 Mar 27;370(13):1189-97
references.pmid: 24670165